BOJ Says Gov Ueda Hospitalized, Will Miss Policy Meeting
By Megumi Fujikawa
TOKYO--Bank of Japan Gov. Kazuo Ueda has been hospitalized and is expected to miss next week's monetary policy meeting, the central bank said Wednesday.
Ueda is anticipated to remain in hospital for treatment of an infected liver cyst for about two weeks but will continue to perform his duties remotely as needed, the BOJ said.
Deputy Gov. Ryozo Himino will serve as acting chairman for the upcoming June 15-16 monetary policy meeting, while Deputy Gov. Shinichi Uchida will conduct the post-meeting press conference, the bank said.
Ueda is expected to recover in time to attend the subsequent meeting in late July, the central bank said.
The news comes at a delicate time for Japanese monetary policy steering as officials assess the economy's ability to absorb higher rates while the Iran crisis generates uncertainty about the trajectory for growth and inflation.
Markets have been almost fully pricing in a potential interest-rate hike at next week's meeting.
Ueda's absence is unlikely to significantly change the bank's rate decision, as policymakers, including the governor himself, have voiced growing concerns that higher oil prices triggered by the Middle East conflict will accelerate underlying inflation.
Write to Megumi Fujikawa at megumi.fujikawa@wsj.com
(END) Dow Jones Newswires
June 10, 2026 06:28 ET (10:28 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
The 10 Best Companies to Invest in Now
3 Stocks to Sell and 3 Stocks to Buy for October
14 Elite Funds and ETFs, and 5 Popular Funds That Just Missed the Mark
The Top Funds for a Simpler Retirement Portfolio
